Cargando…
DNA Methylation in Colorectal cancer—Impact on Screening and Therapy Monitoring Modalities?
Colorectal cancer (CRC) is a common malignancy. It arises from benign neoplasms and evolves into adenocarcinomas through a stepwise histological progression sequence, proceeding from either adenomas or hyperplastic polyps/serrated adenomas. Genetic alterations have been associated with specific step...
Autores principales: | Zitt, Marion, Zitt, Matthias, Müller, Hannes M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851076/ https://www.ncbi.nlm.nih.gov/pubmed/17325426 http://dx.doi.org/10.1155/2007/891967 |
Ejemplares similares
-
Circulating Cell-Free DNA in Plasma of Locally Advanced Rectal Cancer Patients Undergoing Preoperative Chemoradiation: A Potential Diagnostic Tool for Therapy Monitoring
por: Zitt, Matthias, et al.
Publicado: (2008) -
Dickkopf-3 As a New Potential Marker for Neoangiogenesis in Colorectal Cancer: Expression in Cancer Tissue and Adjacent Non-Cancerous Tissue
por: Zitt, Matthias, et al.
Publicado: (2008) -
14-3-3 Sigma And p53 Expression in Gastric Cancer and Its Clinical Applications
por: Mühlmann, Gilbert, et al.
Publicado: (2010) -
Circulating Nucleic Acids in Plasma or Serum (CNAPS) as Prognostic and Predictive Markers in Patients with Solid Neoplasias
por: Goebel, Georg, et al.
Publicado: (2005) -
Role of etelcalcetide in the management of secondary hyperparathyroidism in hemodialysis patients: a review on current data and place in therapy
por: Friedl, Claudia, et al.
Publicado: (2018)